Clinical trial
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
NCT06629428
Study timeline
Study start (actual)2025-11-13Date precision: day
Registry last updated2026-02-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
UblituximabDRUG · verified · RxNorm: ublituximab
Sponsors & collaborators
Georgia State Universitylead sponsor
Atlanta Neuroscience Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06629428 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.